← FDA Drug Approvals (Drugs@FDA)

CLOFARABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2019-02-22

Drug application

FDA Application #

ANDA212034

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOFARABINE

Generic name

Clofarabine

Active ingredients

CLOFARABINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ACCORD HLTHCARE

First approval

2019-02-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown